Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Nuyts

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
The Lancet. Oncology|August 1, 2017
The true value of altered fractionation in head and neck cancerSandra Nuyts
The Lancet. Oncology|July 9, 2023
Improving functional outcomes for patients with head and neck cancerSandra Nuyts
Cancers|April 5, 2016
HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment StrategiesRüveyda Dok, Sandra Nuyts
The Lancet. Oncology|June 5, 2010
Parotid gland function after radiotherapyPiet Dirix, Sandra Nuyts
The Lancet. Oncology|February 5, 2010
Evidence-based organ-sparing radiotherapy in head and neck cancerPiet Dirix, Sandra Nuyts
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|April 27, 2017
Radiologic Differences between Human Papillomavirus-Related and Human Papillomavirus-Unrelated Oropharyngeal Carcinoma on Diffusion-Weighted ImagingSarah Deschuymer, Sandra Nuyts
Onkologie|August 8, 2012
Radiotherapy for head and neck cancer: an increasing dependence on innovative imagingSandra Nuyts, Alysa Fairchild
International Journal of Radiation Oncology, Biology, Physics|April 6, 2010
Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinomaPiet Dirix, Sandra Nuyts
Cancer Medicine|February 17, 2016
The role of stem cells in the prevention and treatment of radiation-induced xerostomia in patients with head and neck cancerDaan Nevens, Sandra Nuyts
The British Journal of Radiology|October 4, 2017
Can sparing of the superficial contralateral parotid lobe reduce xerostomia following radiotherapy for head and neck cancer?Daan Nevens, Sandra Nuyts
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
The Lancet. Oncology|August 1, 2017
The true value of altered fractionation in head and neck cancerSandra Nuyts
The Lancet. Oncology|July 9, 2023
Improving functional outcomes for patients with head and neck cancerSandra Nuyts
Cancers|April 5, 2016
HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment StrategiesRüveyda Dok, Sandra Nuyts
The Lancet. Oncology|June 5, 2010
Parotid gland function after radiotherapyPiet Dirix, Sandra Nuyts
The Lancet. Oncology|February 5, 2010
Evidence-based organ-sparing radiotherapy in head and neck cancerPiet Dirix, Sandra Nuyts
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|April 27, 2017
Radiologic Differences between Human Papillomavirus-Related and Human Papillomavirus-Unrelated Oropharyngeal Carcinoma on Diffusion-Weighted ImagingSarah Deschuymer, Sandra Nuyts
Onkologie|August 8, 2012
Radiotherapy for head and neck cancer: an increasing dependence on innovative imagingSandra Nuyts, Alysa Fairchild
International Journal of Radiation Oncology, Biology, Physics|April 6, 2010
Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinomaPiet Dirix, Sandra Nuyts
Cancer Medicine|February 17, 2016
The role of stem cells in the prevention and treatment of radiation-induced xerostomia in patients with head and neck cancerDaan Nevens, Sandra Nuyts
The British Journal of Radiology|October 4, 2017
Can sparing of the superficial contralateral parotid lobe reduce xerostomia following radiotherapy for head and neck cancer?Daan Nevens, Sandra Nuyts
Pageof 21